Here's the live share price of Shukra Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Shukra Pharmaceuticals has gained 158.57% CAGR. Over the past year, the corresponding return has been 371.88%.
Shukra Pharmaceuticals’s current P/E of 129.99x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Shukra Pharmaceuticals | 10.28 | 59.45 | 113.81 | 19.82 | 371.88 | 205.24 | 158.57 |
Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.70 |
Torrent Pharmaceuticals | -1.10 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.50 |
Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
Lupin | 2.60 | 3.02 | 4.40 | 1.91 | -10.64 | 46.79 | 14.35 |
Abbott India | -0.85 | -4.90 | -2.43 | 2.84 | 7.47 | 21.30 | 13.54 |
Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.40 | -12.19 | 18.95 | 13.98 |
Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.20 | 42.38 | 18.91 | 76.49 | 32.85 |
Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.60 | -2.30 | 24.69 | 9.19 |
Cohance Lifesciences | -2.30 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.30 |
Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.10 |
Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
Over the last one year, Shukra Pharmaceuticals has gained 371.88% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Shukra Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Day | SMA | EMA |
---|---|---|
5 | 27.79 | 28.55 |
10 | 27.74 | 27.75 |
20 | 25.47 | 26.1 |
50 | 22.13 | 22.85 |
100 | 18.13 | 20.45 |
200 | 18.16 | 17.79 |
In the latest quarter, Shukra Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.11%, FII holding unchanged at 0.00%, and public shareholding unchanged at 48.93% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 12, 2025, 11:22 PM IST | Shukra Pharma - Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of SEBI Listing Regulations For Annual G |
Sep 12, 2025, 11:18 PM IST | Shukra Pharma - Intimation Of Record Date For Final Dividend For Financial Year 2024-2025. |
Sep 12, 2025, 11:09 PM IST | Shukra Pharma - Corrigendum To The Notice Of 32ND Annual General Meeting And Annual Report (2024-25) Of The Company |
Sep 10, 2025, 4:18 PM IST | Shukra Pharma - Announcement Under Regulation 30 Of SEBI (LODR)- Strategic PAN India Distribution Tie-Up |
Sep 09, 2025, 1:01 AM IST | Shukra Pharma - Reg. 34 (1) Annual Report. |
Shukra Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/03/1993 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1993PLC019079 and registration number is 019079. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 32.59 Cr. and Equity Capital is Rs. 43.79 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Shukra Pharmaceuticals is ₹30.04 as on Sep 17, 2025.
The Shukra Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Shukra Pharmaceuticals is ₹1,315.39 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Shukra Pharmaceuticals are ₹30.04 and ₹30.04.
The 52-week high/low is the highest and lowest price at which Shukra Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Shukra Pharmaceuticals is ₹29.46 and 52-week low of Shukra Pharmaceuticals is ₹5.75 as on Sep 17, 2025.
The Shukra Pharmaceuticals has shown returns of 1.97% over the past day, 59.45% for the past month, 113.81% over 3 months, 371.88% over 1 year, 205.24% across 3 years, and 158.57% over 5 years.
P/E ratio of and PB ratio of Shukra Pharmaceuticals are 129.99 and 24.23 on Sep 17, 2025. While the company gives a dividend yield of 0.03 per annum.